Introduction to this special issue “Breast Cancer Metastasis”

por Schiemann, William P.
Publicado 2020

Bullseye!: hitting your strategic targets through high-impact

por Schiemann, William A, Lingle, John H
Publicado 2005

β(3) Integrin and Src facilitate transforming growth factor-β mediated induction of epithelial-mesenchymal transition in mammary epithelial cells

por Galliher, Amy J, Schiemann, William P
Publicado 2006

Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-β signaling and metastasis

por Wendt, Michael K, Schiemann, William P
Publicado 2009

Sox4, EMT programs, and the metastatic progression of breast cancers: mastering the masters of EMT

por Parvani, Jenny G, Schiemann, William P
Publicado 2013

Therapeutic opportunities for targeting microRNAs in cancer

por Taylor, Molly A, Schiemann, William P
Publicado 2014

ECO/siRNA nanoparticles and breast cancer metastasis

por Lu, Zheng-Rong, Schiemann, William P.
Publicado 2015

Tipping the balance between good and evil: aberrant 14-3-3ζ expression drives oncogenic TGF-β signaling in metastatic breast cancers

por Morrison, Chevaun D., Schiemann, William P.
Publicado 2015

Telomerase in Cancer: Function, Regulation, and Clinical Translation

por Robinson, Nathaniel J., Schiemann, William P.
Publicado 2022

Amplification and Quantitation of Telomeric Extrachromosomal Circles

por Robinson, Nathaniel J., Schiemann, William P.
Publicado 2023

Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition Facilitates Epidermal Growth Factor-Dependent Breast Cancer Progression

por Wendt, Michael K., Smith, Jason A., Schiemann, William P.
Publicado 2010

Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab

por Gollamudi, Jahnavi, Parvani, Jenny G, Schiemann, William P, Vinayak, Shaveta
Publicado 2016

In vivo Dual Substrate Bioluminescent Imaging

por Wendt, Michael K., Molter, Joseph, Flask, Christopher A., Schiemann, William P.
Publicado 2011

STAT3 and epithelial–mesenchymal transitions in carcinomas

por Wendt, Michael K, Balanis, Nikolas, Carlin, Cathleen R, Schiemann, William P
Publicado 2014

lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing α6 Integrin/CD49f Expression in Breast Cancer Stem Cells

por Parker, Kimberly A., Gooding, Alex J., Valadkhan, Saba, Schiemann, William P.
Publicado 2021

The use of cystatin C to inhibit epithelial–mesenchymal transition and morphological transformation stimulated by transforming growth factor-β

por Sokol, Jonathan P, Neil, Jason R, Schiemann, Barbara J, Schiemann, William P
Publicado 2005

Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer

por Wendt, Michael K., Taylor, Molly A., Schiemann, Barbara J., Schiemann, William P.
Publicado 2011

Mutant p53 dictates the oncogenic activity of c-Abl in triple-negative breast cancers

por Morrison, Chevaun D, Chang, Jenny C, Keri, Ruth A, Schiemann, William P
Publicado 2017

β3 Integrin–EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells

por Balanis, Nikolas, Yoshigi, Masaaki, Wendt, Michael K., Schiemann, William P., Carlin, Cathleen R.
Publicado 2011

Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β

por Parvani, Jenny G., Galliher-Beckley, Amy J., Schiemann, Barbara J., Schiemann, William P.
Publicado 2013